402 related articles for article (PubMed ID: 29099056)
61. Pharmacological activation of dimethylarginine dimethylaminohydrolase (DDAH) activity by inorganic nitrate and DDAH inhibition by N
Bollenbach A; Tsikas D
Amino Acids; 2019 Mar; 51(3):483-494. PubMed ID: 30536052
[TBL] [Abstract][Full Text] [Related]
62. The dimethylarginine (ADMA)/nitric oxide pathway in the brain and periphery of rats with thioacetamide-induced acute liver failure: Modulation by histidine.
Milewski K; Hilgier W; Albrecht J; Zielińska M
Neurochem Int; 2015 Sep; 88():26-31. PubMed ID: 25523831
[TBL] [Abstract][Full Text] [Related]
63. Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells.
Osanai T; Saitoh M; Sasaki S; Tomita H; Matsunaga T; Okumura K
Hypertension; 2003 Nov; 42(5):985-90. PubMed ID: 14557285
[TBL] [Abstract][Full Text] [Related]
64. Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs.
Liu H; Qu X; Liang Z; Chen W; Xia W; Song Y
Biochem Biophys Res Commun; 2008 Dec; 377(3):884-8. PubMed ID: 18951871
[TBL] [Abstract][Full Text] [Related]
65. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.
Pullamsetti S; Kiss L; Ghofrani HA; Voswinckel R; Haredza P; Klepetko W; Aigner C; Fink L; Muyal JP; Weissmann N; Grimminger F; Seeger W; Schermuly RT
FASEB J; 2005 Jul; 19(9):1175-7. PubMed ID: 15827267
[TBL] [Abstract][Full Text] [Related]
66. A novel mass spectrometry-based method for simultaneous determination of asymmetric and symmetric dimethylarginine, l-arginine and l-citrulline optimized for LC-MS-TOF and LC-MS/MS.
Wiśniewski J; Fleszar MG; Piechowicz J; Krzystek-Korpacka M; Chachaj A; Szuba A; Lorenc-Kukula K; Masłowski L; Witkiewicz W; Gamian A
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28436051
[TBL] [Abstract][Full Text] [Related]
67. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
Wakino S; Hayashi K; Tatematsu S; Hasegawa K; Takamatsu I; Kanda T; Homma K; Yoshioka K; Sugano N; Saruta T
Hypertens Res; 2005 Mar; 28(3):255-62. PubMed ID: 16097370
[TBL] [Abstract][Full Text] [Related]
68. From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases.
Zakrzewicz D; Eickelberg O
BMC Pulm Med; 2009 Jan; 9():5. PubMed ID: 19178698
[TBL] [Abstract][Full Text] [Related]
69. Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis.
Mookerjee RP; Malaki M; Davies NA; Hodges SJ; Dalton RN; Turner C; Sen S; Williams R; Leiper J; Vallance P; Jalan R
Hepatology; 2007 Jan; 45(1):62-71. PubMed ID: 17187433
[TBL] [Abstract][Full Text] [Related]
70. Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells.
Xin HY; Jiang DJ; Jia SJ; Song K; Wang GP; Li YJ; Chen FP
Thromb Haemost; 2007 May; 97(5):830-8. PubMed ID: 17479195
[TBL] [Abstract][Full Text] [Related]
71. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine.
Yin QF; Fu SH; He P; Xiong Y
Atherosclerosis; 2007 Jan; 190(1):53-61. PubMed ID: 16533509
[TBL] [Abstract][Full Text] [Related]
72. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
Davids M; Richir MC; Visser M; Ellger B; van den Berghe G; van Leeuwen PA; Teerlink T
Metabolism; 2012 Apr; 61(4):482-90. PubMed ID: 22000584
[TBL] [Abstract][Full Text] [Related]
73. Comprehensive analysis of the L-arginine/L-homoarginine/nitric oxide pathway in preterm neonates: potential roles for homoarginine and asymmetric dimethylarginine in foetal growth.
Buck A; Kayacelebi AA; Chobanyan-Jürgens K; Illsinger S; Bohnhorst B; Beckmann B; Hanff E; Das AM; Tsikas D; Lücke T
Amino Acids; 2017 Apr; 49(4):783-794. PubMed ID: 28161799
[TBL] [Abstract][Full Text] [Related]
74. A simple and fast liquid chromatography-tandem mass spectrometry method for measurement of underivatized L-arginine, symmetric dimethylarginine, and asymmetric dimethylarginine and establishment of the reference ranges.
El-Khoury JM; Bunch DR; Reineks E; Jackson R; Steinle R; Wang S
Anal Bioanal Chem; 2012 Jan; 402(2):771-9. PubMed ID: 22124751
[TBL] [Abstract][Full Text] [Related]
75. Health-associated reference values for arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) measured with high-performance liquid chromatography.
Hov GG; Sagen E; Bigonah A; Asberg A
Scand J Clin Lab Invest; 2007; 67(8):868-76. PubMed ID: 17852822
[TBL] [Abstract][Full Text] [Related]
76. The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitro.
Watson CP; Pazarentzos E; Fidanboylu M; Padilla B; Brown R; Thomas SA
Brain Res; 2016 Oct; 1648(Pt A):232-242. PubMed ID: 27431938
[TBL] [Abstract][Full Text] [Related]
77. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension.
Jepson RE; Syme HM; Vallance C; Elliott J
J Vet Intern Med; 2008; 22(2):317-24. PubMed ID: 18371026
[TBL] [Abstract][Full Text] [Related]
78. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
Stühlinger MC; Conci E; Haubner BJ; Stocker EM; Schwaighofer J; Cooke JP; Tsao PS; Pachinger O; Metzler B
Cardiovasc Res; 2007 Jul; 75(2):417-25. PubMed ID: 17559823
[TBL] [Abstract][Full Text] [Related]
79. The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury.
Ferrigno A; Di Pasqua LG; Berardo C; Siciliano V; Rizzo V; Adorini L; Richelmi P; Vairetti M
PLoS One; 2018; 13(1):e0191430. PubMed ID: 29346429
[TBL] [Abstract][Full Text] [Related]
80. Intracerebral Administration of S-Adenosylhomocysteine or S-Adenosylmethionine Attenuates the Increases in the Cortical Extracellular Levels of Dimethylarginines Without Affecting cGMP Level in Rats with Acute Liver Failure.
Czarnecka A; Milewski K; Jaźwiec R; Zielińska M
Neurotox Res; 2017 Jan; 31(1):99-108. PubMed ID: 27604291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
